HCSG (Healthcare Services Group)
Insider Trading Activity
Every open-market purchase and sale reported by HCSG officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-05 | Andrew Kush | EVP & Chief Operating Officer | Sell | — | — |
| 2026-07-02 | THOMAS GERARD WHALEN | Director | A | — | — |
| 2026-07-02 | Laura K Grant | Director | A | — | — |
| 2026-07-02 | Andrew M Brophy | SVP & Chief Accounting Officer | A | — | — |
| 2026-07-02 | Kurt Simmons JR | Director | A | — | — |
| 2026-05-29 | Vikas Singh | EVP & Chief Financial Officer | MIXED | — | — |
| 2026-05-28 | Daniela Castagnino | Director | A | — | — |
| 2026-05-28 | THOMAS GERARD WHALEN | Director | A | — | — |
| 2026-05-28 | Diane S Casey | Director | A | — | — |
| 2026-05-28 | Dino D Ottaviano | Director | A | — | — |
| 2026-05-28 | Thomas Michael Gallagher | Director | A | — | — |
| 2026-05-28 | Jude Visconto | Director | A | — | — |
| 2026-05-28 | Laura K Grant | Director | A | — | — |
| 2026-05-28 | Vikas Singh | EVP & Chief Financial Officer | MIXED | — | — |
| 2026-05-28 | Kurt Simmons JR | Director | A | — | — |
| 2026-04-02 | Kurt Simmons JR | Director | A | — | — |
| 2026-04-02 | Laura K Grant | Director | A | — | — |
| 2026-04-02 | THOMAS GERARD WHALEN | Director | A | — | — |
| 2026-02-26 | Andrew M Brophy | SVP & Chief Accounting Officer | MIXED | — | — |
| 2026-02-26 | Theodore WAHL | President & CEO | MIXED | — | — |
| 2026-02-26 | JOHN CHRISTOPHER SHEA | EVP & Chief Admin. Officer | MIXED | — | — |
| 2026-02-26 | Patrick J Orr | EVP & Chief Revenue Officer | MIXED | — | — |
| 2026-02-26 | Jason J Bundick | EVP/Gen. Counsel/Corp. Secty. | MIXED | — | — |
| 2026-02-26 | Andrew Kush | EVP & Chief Operating Officer | MIXED | — | — |
| 2026-02-20 | Patrick J Orr | EVP & Chief Revenue Officer | Sell | — | — |
| 2026-02-19 | JOHN CHRISTOPHER SHEA | EVP & Chief Admin. Officer | MIXED | — | — |
| 2026-02-19 | Theodore WAHL | President & CEO | MIXED | — | — |
| 2026-02-19 | Patrick J Orr | EVP & Chief Revenue Officer | MIXED | — | — |
| 2026-01-06 | JOHN CHRISTOPHER SHEA | EVP & Chief Admin. Officer | MIXED | — | — |
| 2026-01-06 | Theodore WAHL | President & CEO | MIXED | — | — |
| 2026-01-06 | Jason J Bundick | EVP/Gen. Counsel/Corp. Secty. | MIXED | — | — |
| 2026-01-06 | Patrick J Orr | EVP & Chief Revenue Officer | MIXED | — | — |
| 2026-01-06 | Vikas Singh | EVP & Chief Financial Officer | MIXED | — | — |
| 2026-01-06 | Andrew Kush | EVP & Chief Operating Officer | MIXED | — | — |
| 2026-01-06 | Andrew M Brophy | SVP & Chief Accounting Officer | MIXED | — | — |
| 2026-01-05 | Kurt Simmons JR | Director | A | — | — |
| 2026-01-05 | THOMAS GERARD WHALEN | Director | A | — | — |
| 2025-10-29 | Andrew Kush | EVP & Chief Operating Officer | D | — | — |
| 2025-10-29 | Jason J Bundick | EVP/Gen. Counsel/Corp. Secty. | D | — | — |
| 2025-10-02 | THOMAS GERARD WHALEN | Director | A | — | — |
| 2025-10-02 | Kurt Simmons JR | Director | A | — | — |
| 2025-07-30 | JOHN CHRISTOPHER SHEA | EVP & Chief Admin. Officer | Sell | — | — |
| 2025-07-02 | Kurt Simmons JR | Director | A | — | — |
| 2025-07-02 | THOMAS GERARD WHALEN | Director | A | — | — |
| 2025-06-04 | THOMAS GERARD WHALEN | Director | A | — | — |
| 2025-05-29 | John J McFadden JR | Director | A | — | — |
| 2025-05-29 | Vikas Singh | EVP & Chief Financial Officer | A | — | — |
| 2025-05-29 | Kurt Simmons JR | Director | A | — | — |
| 2025-05-29 | Daniela Castagnino | Director | A | — | — |
| 2025-05-29 | Laura K Grant | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 2,043,826 | — |
| — | President & CEO | 641,176 | — |
| — | Director | 482,050 | — |
| — | Divisional Vice President | 154,676 | — |
| — | Executive Vice President | 127,828 | — |
| — | President | 83,336 | — |
| — | EVP & Chief Admin. Officer | 39,099 | — |
| — | Director | 30,770 | — |
| — | EVP/Gen. Counsel/Corp. Secty. | 29,812 | — |
| — | Director | 27,066 | — |
| — | EVP & Chief Revenue Officer | 25,456 | — |
| — | EVP & Chief Operating Officer | 22,741 | — |
| — | Director | 21,474 | — |
| — | SVP & Chief Accounting Officer | 19,922 | — |
| — | Director | 18,314 | — |
| — | Director | 15,409 | — |
| — | Director | 14,975 | — |
| — | Director | 14,975 | — |
| — | Director | 14,975 | — |
| — | Director | 13,006 | — |
| — | Chief Compliance Officer | 12,582 | — |
| — | Executive Vice President & COO | 8,151 | — |
| — | EVP & Chief Revenue Officer | 7,417 | — |
| — | — | 6,750 | — |
| — | Director | 5,357 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the HCSG quote page; the site-wide leaderboard is on the insider transactions hub.